Approval of First Therapy to Counteract Muscle Loss in Spinal Muscular Atrophy
15/09/2026
Introduction The FDA has granted approval for apitegromab (Isembyld) injection, designed to treat spinal muscular atrophy (SMA) in both adults
Pennsylvania officials have reported a fourth measles-associated death. Detalles del caso El último fallecimiento involucra a un residente de 18…
Read more →
Introduction The FDA has granted approval for apitegromab (Isembyld) injection, designed to treat spinal muscular atrophy (SMA) in both adults
Resumen del Estudio Un régimen de dos fármacos ha mostrado ser no inferior a un régimen de tres fármacos como
Switching to a weekly oral investigational regimen of islatravir and lenacapavir (Sunlenca) was just as effective as daily oral standard-of-care
According to a recent Danish cohort study, nearly half of adults who initiated semaglutide (Wegovy) for obesity management discontinued treatment
El uso de agonistas del receptor GLP-1 se asoció con un aumento de eventos acumulativos de la vesícula biliar y